Literature DB >> 24264562

A psychosocial model of a medical problem: Maternal phenylketonuria.

S Shiloh1, S E Waisbren, H L Levy.   

Abstract

Treatment of maternal phenylketonuria (PKU) consists of a low phenylalanine diet, begun before conception, which is believed to prevent mental retardation, microcephaly, and congenital heart disease in offspring of women with PKU. Experiences in treating these women indicate that their cooperation with medical recommendations is generally poor. We present a psychosocial model on adjustment and coping in maternal PKU. The proposed model defines four stages in the reproductive years of women with PKU, each of which has specific behavioral goals. The four stages are: (1) prevention of unplanned pregnancies; (2) reproductive decision-making; (3) diet initiation; and (4) diet continuation through pregnancy. Review of the literature on the different behaviors expected at the different stages enabled indentification of psychosocial factors that may explain success or failure in achieving the goals at each stage. Based on this theoretical framework, practical implications for treating women with PKU have been suggested.

Entities:  

Year:  1989        PMID: 24264562     DOI: 10.1007/BF01324649

Source DB:  PubMed          Journal:  J Prim Prev        ISSN: 0278-095X


  23 in total

1.  Chance, choice, and the future of reproduction.

Authors:  W B Miller
Journal:  Am Psychol       Date:  1983-11

2.  Development of a sex anxiety inventory.

Authors:  L H Janda; K E O'Grady
Journal:  J Consult Clin Psychol       Date:  1980-04

3.  Phenylketonuria: epitome of human biochemical genetics (second of two parts).

Authors:  C R Scriver; C L Clow
Journal:  N Engl J Med       Date:  1980-12-11       Impact factor: 91.245

4.  Genetic counseling: provision and reception of information.

Authors:  A Lippman-Hand; F C Fraser
Journal:  Am J Med Genet       Date:  1979

Review 5.  Maternal phenylketonuria. Review with emphasis on pathogenesis.

Authors:  H L Levy
Journal:  Enzyme       Date:  1987

6.  Diet policies of PKU clinics in the United States.

Authors:  V E Schuett; E S Brown
Journal:  Am J Public Health       Date:  1984-05       Impact factor: 9.308

7.  Tyrosine supplementation during pregnancy in a woman with classical phenylketonuria. A case report.

Authors:  R R Lenke; R Koch; K Fishler; L D Platt
Journal:  J Reprod Med       Date:  1983-06       Impact factor: 0.142

Review 8.  A social-psychological perspective on successful community control of high blood pressure: a review.

Authors:  S V Kasl
Journal:  J Behav Med       Date:  1978-12

9.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

10.  Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant.

Authors:  R A MacCready
Journal:  J Pediatr       Date:  1974-09       Impact factor: 4.406

View more
  1 in total

1.  Agoraphobia in phenylketonuria.

Authors:  S E Waisbren; H L Levy
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.